Earnings date: Thursday, July 30, 2026
Event: 2026Q2 Earnings Call
Primary setup: This is a guidance-credibility and execution quarter more than a simple headline EPS event. Management already signaled that 2Q would carry concentrated pressure from China, higher input costs ahead of price realization, and a planned water-treatment restructuring charge. The questions are whether those issues remain contained within the reduced full-year outlook—and whether North American demand, pricing, and Leonard Valve integration provide enough offset to support a stronger second half.
AOS enters the report with expectations reset following a weak 1Q and a late-April reduction to 2026 guidance. The company guided to $3.70–$4.00 of adjusted EPS and 2%–4% sales growth for 2026, down from the prior $3.85–$4.15 adjusted-EPS range. The revised outlook reflected a weaker recovery timeline in China and reduced expected commercial-water-heater prebuy activity after the Department of Energy delayed enforcement of a planned October 2026 rule.
The key nuance: management explicitly framed 2Q as the most difficult near-term period. On the 1Q call, it said 2Q EPS should represent roughly 25% of the full-year guidance midpoint—which implies approximately $0.96 of adjusted EPS using the $3.85 midpoint. That is a useful internal cadence marker, not a Street-consensus estimate. Reported GAAP EPS will be lower because AOS expects to record approximately $20 million of pre-tax North American water-treatment restructuring and impairment charges in 2Q.
The stock closed at $62.19 on July 29, down roughly 9.0% year-to-date, but about 11.5% above its June 1 low. That performance suggests investors have already discounted a meaningful share of the China and margin-risk narrative, but it also leaves little tolerance for another guide-down or evidence that the anticipated 2H price/cost recovery is slipping.
China is the central issue. In 1Q, China third-party sales fell 17% in local currency, with government appliance subsidies largely ended and premium consumer demand still weak. China represented $162.4 million of 1Q sales—about 17% of consolidated sales—so its earnings impact is meaningfully larger than its revenue mix alone implies.
Management’s 2Q setup was deliberately cautious:
Investor focus: A result merely consistent with the planned China inventory correction may be manageable. More concerning would be a deeper demand decline, incremental price competition, adverse distributor/channel commentary, or another delay in resolving the China strategic review. Conversely, any clarity on a partnership, restructuring, or other strategic path could reduce a persistent valuation overhang.
North America remains the earnings engine, but 2Q has crosscurrents.
Potential supports - Management expects some recovery from the 1Q weather-related disruption at its Ashland City, Tennessee facility, although it characterized the catch-up benefit as modest. - AOS implemented 4%–7% price increases across most North American water-heater and boiler products, effective around mid-May. - Leonard Valve is tracking well operationally: it contributed about $16 million of 1Q sales and AOS still expects roughly $70 million of 2026 sales, with double-digit growth. - Boiler demand/backlog remains a relative bright spot; full-year boiler sales are expected to rise 6%–8%, primarily pricing-led but also supported by commercial backlog.
Headwinds - Price realization is expected to become more meaningful in 3Q, while higher steel, freight, diesel, and other input costs hit in 2Q. - The company raised its assumption for steel costs to approximately +15% year over year and expects freight, non-steel materials, and tariffs to add about 3% to total-company cost of goods sold in 2026. - Residential water-heater industry demand remains expected to be flat to down for the full year, reflecting weak new construction. - The DOE enforcement delay reduces the expected commercial prebuy benefit in 2Q and 3Q.
Investor focus: The critical datapoint is not simply North American revenue growth, which may benefit from modest prebuy ahead of the May price increase. It is whether North America margin is holding near the company’s approximately 24% full-year target despite the temporary 2Q price/cost mismatch.
AOS expects to record roughly $20 million pre-tax of restructuring and impairment charges in 2Q related to the North American water-treatment business. Most of the charge is expected to be non-cash. The program includes footprint optimization and brand rationalization and is projected to generate $6 million–$8 million of annual savings beginning in 2027.
This makes 2Q GAAP results less comparable and shifts attention to the underlying business:
Investor focus: Investors should distinguish between the near-term accounting charge and the operational question: is the business actually progressing toward its stated margin target, or is another reset likely required?
| Metric | 2Q25 actual | 2Q26 setup / key comparison |
|---|---|---|
| Revenue | $1.011B | North America may benefit from modest price-related demand timing and Leonard Valve; Rest of World faces a sharp China decline. |
| Diluted EPS | $1.07 | Management indicated 2Q EPS around 25% of the midpoint of annual guidance; approximately $0.96 adjusted EPS is a useful implied cadence marker. |
| North America margin | 25.4% | Cost pressure before full price realization makes this a tougher comparison; AOS targets about 24% for FY26. |
| Rest of World margin | 10.5% | China inventory reduction and high decrementals imply a materially weaker year-over-year comparison. |
| Free cash flow | $139.9M for 1H25 | Watch working-capital normalization after unusually strong 1Q cash generation driven partly by payment timing. |
Note: The implied adjusted-EPS figure is derived from management’s own stated quarterly cadence and its $3.70–$4.00 full-year adjusted-EPS range; it is not a published analyst-consensus estimate.
A constructive report would feature:
The principal downside scenario is not just an EPS miss—it is a change in the full-year earnings algorithm:
The report’s directional read-through will hinge on whether 2Q is simply the trough management described in April. China and price/cost dynamics are supposed to be worst in 2Q; thus, an in-line quarter accompanied by maintained guidance, stable North American margins, and confidence in 3Q price realization could be enough to support a more constructive view of the second half.
However, investors should be wary of treating an adjusted-EPS beat as sufficient. The more important tests are: China inventory normalization, the durability of North American demand and share, price realization versus inflation, and whether the company can still credibly deliver a second-half earnings recovery.